Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
291 studies found for:    "Anemia, Aplastic"
Show Display Options
Rank Status Study
1 Completed
Has Results
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)
Condition: Anemia, Aplastic
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide 150mg;   Drug: Cyclophosphamide 100mg;   Drug: Cyclophosphamide 50mg
2 Recruiting Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia
Condition: Anemia, Aplastic
Intervention: Drug: Cyclophosphamide,Campath IH and TBI
3 Recruiting Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)
Condition: Anemia, Aplastic
Interventions: Drug: Eltrombopag;   Drug: Placebo (for Eltrombopag)
4 Unknown  Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia
Condition: Anemia, Aplastic
Interventions: Procedure: Ex Vivo Immunotherapy;   Drug: Ex vivo immunotherapy
5 Unknown  Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
Condition: Anemia, Aplastic
Interventions: Drug: Sirolimus;   Drug: Cyclosporine
6 Not yet recruiting Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia
Condition: Anemia, Aplastic
Interventions: Drug: rhTPO;   Drug: placebo
7 Completed Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor
Condition: Anemia, Aplastic
Intervention: Procedure: Bone marrow transplant
8 Unknown  Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)
Condition: Anemia, Aplastic
Intervention: Drug: cyclophosphamide, fludarabine , thymoglobulin
9 Recruiting Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Biological: Romiplostim
10 Unknown  Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Cy-ATG;   Drug: Flu-ATG
11 Completed Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Biological: Intravenous bone marrow mesenchymal stem cells infusion
12 Terminated
Has Results
Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Cytoxan;   Drug: Campath;   Radiation: Total Body Irradiation (TBI);   Drug: FK-506;   Drug: Methotrexate;   Procedure: Stem cell infusion
13 Active, not recruiting Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment
Conditions: Anemia, Aplastic;   Anemia, Hypoplastic
Interventions: Drug: h-ATG (ATGAM );   Drug: Cyclosporine (Gengraf )
14 Unknown  Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA)
Condition: Aplastic Anemia
Intervention: Other: Cyclophosphosphamide, TBI
15 Suspended Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alefacept
16 Withdrawn Alemtuzumab and Rituximab in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alemtuzumab and Rituximab
17 Unknown  Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: cyclophosphamide,cyclosporine A
18 Completed Combination Therapy of Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Intervention: Drug: Cyclosporine
19 Completed Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
20 Recruiting Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Drug: Rabbit antithymoglobulin (ATG);   Procedure: Adipose derived mesenchymal stem cells ( AD-MSCs);   Procedure: AD-MSC transdifferentiated HSCs (AD-HSCs)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.